Cumberland pharmaceuticals inc

Major-Pharmaceuticals

CPIX


2525 West End Avenue
Nashville , TN 37203

Executive/
Director

Price

  • Last Close
  • $ 1.38
    $ +0.02 1.47 %
    Aug 29, 2024
  • 52-Week High/Low
  • $2.3 - $1.31
  • YTD
  • -20.7%

  • Trading Volume
  • 4
  • Market Cap Full
  • $ 19.7M
  • Shares Outstanding
  • 14.3M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 11.4% -14.6% 26.2% -9.2% -3.7% -5% 3.1% -39.6% -13.3% -3.5%
Q2 7.4% 0.2% 0.9% -8% 9.4% 4% -5.9% -26.2% -24.6% 3%
Q3 -19.3% 11.3% 0.9% -6.9% -8.3% 8% -5.6% 15.9% 28.6% -
Q4 -8.8% 9.8% 4.3% 5.6% -13.5% -8.4% 73.6% -6.6% -2.3% -
J F M A M J J A S O N D
2024 19.5% 2.4% -21.1% 3% - - - - - - - -
2023 20% -15.6% -14.5% -12.3% -5.9% -8.7% 3.4% 8.6% 14.6% - -11.1% 3.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    17%-12%5%34%-18%-16%-42%59%-52%-23%-21%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.01 - -0.15 - -0.07 0.01 -0.09 0.01
Q2 0.07 0.03 0.07 -0.05 -0.04 -0.06 0.08 -0.09 0.06
Q3 0.03 0.01 0.01 -0.11 -0.13 -0.03 -0.07 -0.03 -0.07
Q4 0.02 0.05 0.01 -0.14 -0.06 -0.06 -0.26 -0.17 -
A 0.1 0.1 0.1 -0.5 -0.2 -0.2 -0.2 -0.4 -1.3877787807814E-17

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 15.4 15.2 14.9 14.8 14.4
Jun 15.7 15.5 15.2 15.1 14.8 14.4
Sep 15.6 15.4 15.1 14.9 14.7 14.4
Dec 15.5 15.2 15 14.8 14.5 14.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.9 1.1 0.8 1 0.6
Fixed Asset Turnover 14 12 9.3 12 10.3
Total Asset Turnover 0.5 0.4 0.4 0.5 0.4
Leverage
Debt Ratio 0.4 0.3 0.3 0.4 0.3
Debt – Equity Ratio 0.4 0.4 0.3 0.4 0.4
Interest Coverage - 2 2 - -
Equity multiplier 0.1 0.1 0.1 0.1 0.1